BABA vs BRSL

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

The Advanced Deterministic Scorecard reveals critical weaknesses: a Piotroski F-Score of just 2/9 indicates severe financial distress, and the absence of an Altman Z-Score prevents safety confirmation. Despite high earnings growth and a bullish analyst recommendation, the stock trades at a massive premium to both Graham ($3.05) and intrinsic value ($2.65), with deteriorating earnings surprises, alarming leverage (Debt/Equity: 3.18), and a dangerously high payout ratio (888.89%). Technical trend is deeply bearish, and recent price performance shows consistent downward momentum, reinforcing structural concerns.